Veracyte (VCYT) Misses Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Veracyte (VCYT) PT Lowered to $11 at Leerink Partners
March 20, 2015 7:57 AM EDTLeerink Partners analyst Dan Leonard maintained an Outperform rating on Veracyte, Inc (NASDAQ: VCYT) but lowered his price target to $11.00 (from $14.00) following Q4 results.
Leonard commented, "VCYT's revenue for 4Q exceeded the Street and our expectations. While test volume growth is... More
